247.72
price up icon1.45%   3.55
after-market アフターアワーズ: 249.90 2.18 +0.88%
loading
前日終値:
$244.17
開ける:
$244.415
24時間の取引高:
1.06M
Relative Volume:
1.12
時価総額:
$15.56B
収益:
$4.44B
当期純損益:
$29.49M
株価収益率:
-13,463.04
EPS:
-0.0184
ネットキャッシュフロー:
$1.19B
1週間 パフォーマンス:
+2.80%
1か月 パフォーマンス:
+3.84%
6か月 パフォーマンス:
+46.26%
1年 パフォーマンス:
+130.22%
1日の値動き範囲:
Value
$238.92
$249.64
1週間の範囲:
Value
$234.36
$249.64
52週間の値動き範囲:
Value
$105.00
$249.64

Jazz Pharmaceuticals Plc Stock (JAZZ) Company Profile

Name
名前
Jazz Pharmaceuticals Plc
Name
セクター
Healthcare (1094)
Name
電話
353-1-634-7800
Name
住所
FIFTH FLOOR, WATERLOO EXCHANGE, DUBLIN
Name
職員
2,890
Name
Twitter
@jazzpharma
Name
次回の収益日
2026-08-04
Name
最新のSEC提出書
Name
JAZZ's Discussions on Twitter

Compare JAZZ vs VRTX, REGN, ARGX, ALNY, RVMD

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
JAZZ icon
JAZZ
Jazz Pharmaceuticals Plc
247.72 15.34B 4.44B 29.49M 1.19B -0.0184
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
522.25 134.41B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
676.23 68.13B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
919.94 57.01B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
321.59 41.79B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
190.46 40.39B 742.00K -1.37B -1.07B -7.0731

Jazz Pharmaceuticals Plc Stock (JAZZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2026-04-10 再開されました Raymond James Outperform
2026-02-27 開始されました Barclays Overweight
2025-11-24 ダウングレード UBS Buy → Neutral
2025-07-15 開始されました Deutsche Bank Buy
2025-03-07 アップグレード UBS Neutral → Buy
2025-02-26 ダウングレード Cantor Fitzgerald Overweight → Neutral
2025-02-13 アップグレード Wells Fargo Equal Weight → Overweight
2024-12-12 アップグレード Morgan Stanley Equal-Weight → Overweight
2024-06-05 開始されました Goldman Buy
2024-01-03 開始されました Robert W. Baird Outperform
2023-11-27 ダウングレード UBS Buy → Neutral
2023-09-29 開始されました Raymond James Mkt Perform
2023-06-12 再開されました Wells Fargo Equal Weight
2022-12-09 アップグレード Goldman Neutral → Buy
2022-06-14 開始されました UBS Buy
2022-04-06 ダウングレード Goldman Buy → Neutral
2021-11-19 再開されました Goldman Buy
2021-10-07 再開されました Jefferies Buy
2021-10-05 開始されました Citigroup Buy
2021-09-23 開始されました Needham Buy
2021-05-19 再開されました JP Morgan Overweight
2021-04-07 再開されました RBC Capital Mkts Outperform
2021-02-05 繰り返されました H.C. Wainwright Buy
2021-02-03 アップグレード Piper Sandler Neutral → Overweight
2021-01-29 ダウングレード Morgan Stanley Overweight → Equal-Weight
2020-12-16 開始されました UBS Buy
2020-11-03 繰り返されました H.C. Wainwright Buy
2020-10-09 繰り返されました H.C. Wainwright Buy
2020-09-14 ダウングレード Goldman Neutral → Sell
2020-09-14 再開されました JP Morgan Overweight
2020-08-06 アップグレード Morgan Stanley Equal-Weight → Overweight
2020-07-28 アップグレード Wolfe Research Peer Perform → Outperform
2020-07-23 アップグレード H.C. Wainwright Neutral → Buy
2020-04-06 開始されました Jefferies Buy
2020-03-12 アップグレード Bernstein Mkt Perform → Outperform
2020-01-08 開始されました Goldman Neutral
2019-08-21 ダウングレード Piper Jaffray Overweight → Neutral
2019-06-11 開始されました Barclays Overweight
2019-03-20 開始されました SunTrust Buy
2018-12-14 開始されました Wolfe Research Peer Perform
2018-11-08 繰り返されました B. Riley FBR Buy
2018-08-08 繰り返されました Stifel Buy
2018-07-11 ダウングレード Morgan Stanley Overweight → Equal-Weight
2018-03-23 繰り返されました H.C. Wainwright Neutral
2018-03-19 アップグレード Morgan Stanley Equal-Weight → Overweight
すべてを表示

Jazz Pharmaceuticals Plc (JAZZ) 最新ニュース

pulisher
09:24 AM

JAZZ Maintains Rating by Truist Securities -- Price Target Lowered to $254 - GuruFocus

09:24 AM
pulisher
Jul 06, 2026

Sleep Apnea Pipeline 2026: Therapies, MOA Insights, and Key Clinical Trial Updates by DelveInsight | Apnimed, Eli Lilly, Incannex Healthcare, Axsome Therapeutics, Jazz Pharma, Bioprojet - Barchart.com

Jul 06, 2026
pulisher
Jul 06, 2026

Jazz Pharmaceuticals Holds Steady Near Resistance as Volume Patterns Signal CautionQuality Factor - dars.gov.et

Jul 06, 2026
pulisher
Jul 06, 2026

Jazz Pharmaceuticals PLC at TD Cowen Oncology Innovation Summit (Virtual) Transcript - GuruFocus

Jul 06, 2026
pulisher
Jul 03, 2026

JAZZJazz Pharmaceuticals plc Options - Finviz

Jul 03, 2026
pulisher
Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) Breakout Keeps Valuation In Focus Following Zepzelca Setback And Ziihera Hopes - simplywall.st

Jul 02, 2026
pulisher
Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) EVP reports RSU tax withholding and retains 47,911 shares - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) CEO shares withheld to cover RSU tax obligations - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) insider RSU tax withholding detailed - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) CFO reports 3,343-share tax withholding - Stock Titan

Jul 02, 2026
pulisher
Jul 02, 2026

Jazz Pharmaceuticals (JAZZ) Price Forecast: Will Breakout Confirm Higher Highs? - FXEmpire

Jul 02, 2026
pulisher
Jul 02, 2026

Jazz Pharmaceuticals stock hits all-time high at 243.39 USD - Investing.com

Jul 02, 2026
pulisher
Jul 02, 2026

Jazz Pharmaceuticals stock hits all-time high at 243.39 USD By Investing.com - Investing.com UK

Jul 02, 2026
pulisher
Jul 01, 2026

Form 144 Jazz Pharmaceuticals Plc For: 1 July By Investing.com - Investing.com Nigeria

Jul 01, 2026
pulisher
Jul 01, 2026

Bruce Cozadd files Form 144 to sell shares — Jazz Pharmaceuticals (NASDAQ: JAZZ) - Stock Titan

Jul 01, 2026
pulisher
Jun 30, 2026

Enterprise value to revenue forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView

Jun 30, 2026
pulisher
Jun 30, 2026

Price to earnings forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView

Jun 30, 2026
pulisher
Jun 30, 2026

Price to book forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView

Jun 30, 2026
pulisher
Jun 30, 2026

Is Jazz Pharmaceuticals (JAZZ) Using AbCellera Deal to Quietly Redefine Its Oncology Strategy? - simplywall.st

Jun 30, 2026
pulisher
Jun 30, 2026

3 Overrated Stocks Walking a Fine Line - Yahoo Finance UK

Jun 30, 2026
pulisher
Jun 30, 2026

Price to sales forward of Jazz Pharmaceuticals plc – NASDAQ:JAZZ - TradingView

Jun 30, 2026
pulisher
Jun 29, 2026

Is HRMY Stock Worth Buying With Neutral Signals and Cheap Valuation? - TradingView

Jun 29, 2026
pulisher
Jun 29, 2026

Jazz Pharmaceuticals' Lung Cancer Drug Setback in Late-Stage Trials: Here's Why the Stock Impact May Be More Limited Than It Looks - AOL.com

Jun 29, 2026
pulisher
Jun 27, 2026

Erica Jefferson Joins Jazz Pharmaceuticals as Chief Communications Officer - hrtoday.in

Jun 27, 2026
pulisher
Jun 26, 2026

JAZZ Forecast — Price Target — Prediction for 2027 - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Jazz Pharmaceuticals' lung cancer drug setback in late-stage trials: Here's why the stock impact may be more limited than it looks - MSN

Jun 26, 2026
pulisher
Jun 26, 2026

Jazz Pharma announces late-stage trial setback for lung cancer therapy - MSN

Jun 26, 2026
pulisher
Jun 26, 2026

Jazz Pharmaceuticals Public Limited Company Actuals & Estimates (NASDAQ:JAZZ) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

Jazz Pharmaceuticals: Why It's Time To Cash Out (Rating Downgrade) (NASDAQ:JAZZ) - Seeking Alpha

Jun 26, 2026
pulisher
Jun 25, 2026

Jazz Pharmaceuticals (JAZZ) Reframed Zepzelca Growth, Is The Stock Still Below Fair Value? - simplywall.st

Jun 25, 2026
pulisher
Jun 25, 2026

Strong Leaders Build Strong Teamsand Strong Teams Change Patients’ LivesJazz Pharmaceuticals - Oncodaily

Jun 25, 2026
pulisher
Jun 25, 2026

Jazz Pharmaceuticals PLC (HAM:J7Z) Stock Price, Trades & News - GuruFocus

Jun 25, 2026
pulisher
Jun 24, 2026

Jazz Pharmaceuticals (JAZZ) Stock Gets Fair Value Boost As Ziihera Views Split Analysts - Yahoo Finance

Jun 24, 2026
pulisher
Jun 24, 2026

Jazz Pharmaceuticals (JAZZ) Expands AbCellera Tie Up As Zepzelca Trial Misses Goal - Yahoo Finance

Jun 24, 2026
pulisher
Jun 23, 2026

Jazz Pharmaceuticals and AbCellera Biologics Inc. (ABCL) Announce Collaboration - Yahoo Finance UK

Jun 23, 2026
pulisher
Jun 23, 2026

Will Zepzelca’s Failed LAGOON Trial in Second-Line SCLC Change Jazz Pharmaceuticals' (JAZZ) Narrative? - simplywall.st

Jun 23, 2026
pulisher
Jun 22, 2026

JAZZ’s Zepzelca fails to meet primary goal in lung cancer study - MSN

Jun 22, 2026
pulisher
Jun 22, 2026

Investor Outlook: Jazz Pharmaceuticals Plc (JAZZ) And Its 14.40% Potential Upside - DirectorsTalk Interviews

Jun 22, 2026
pulisher
Jun 22, 2026

Jazz Pharmaceuticals PLC (JAZZ) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 22, 2026
pulisher
Jun 18, 2026

Jazz Pharmaceuticals (JAZZ) Stock Could Be 73% Below Fair Value After Recent Pullback - simplywall.st

Jun 18, 2026
pulisher
Jun 18, 2026

JAZZ & ABCL Team Up to Develop Next-Generation Solid Tumor Therapies - Yahoo Finance

Jun 18, 2026
pulisher
Jun 18, 2026

A potential billion-dollar deal looks for new ways to beat back cancer - The Business Journals

Jun 18, 2026
pulisher
Jun 18, 2026

Jazz and AbCellera sign deal for T-cell engagers in solid tumours - Pharmaceutical Technology

Jun 18, 2026
pulisher
Jun 18, 2026

Jazz Pharmaceuticals PLC (JAZZ) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

Jazz Pharmaceuticals PLC (JAZZ) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Jazz Pharmaceuticals PLC (JAZZ) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Jazz Pharmaceuticals PLC (JAZZ) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Jazz Pharmaceuticals PLC (JAZZ) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Jazz Pharmaceuticals PLC (JAZZ) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Jazz Pharmaceuticals PLC (JAZZ) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

Insider Sell: Mark Smith Sells Shares of Jazz Pharmaceuticals PL - GuruFocus

Jun 17, 2026

Jazz Pharmaceuticals Plc (JAZZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$112.84
price up icon 1.17%
$57.80
price up icon 1.55%
$36.31
price up icon 2.60%
$79.77
price down icon 2.48%
ONC ONC
$308.96
price down icon 0.16%
$190.46
price up icon 0.25%
大文字化:     |  ボリューム (24 時間):